TP0463518, a novel prolyl hydroxylase inhibitor, specifically induces erythropoietin production in the liver
…, F Io, N Takayama, H Koretsune, E Kunioka… - … of Pharmacology and …, 2019 - ASPET
Prolyl hydroxylase (PHD) 1/2/3 pan inhibitors are known to potentially induce erythropoietin
(EPO) production in both the kidney and liver. The 2-[[1-[[6-(4-chlorophenoxy)pyridin-3-yl]…
(EPO) production in both the kidney and liver. The 2-[[1-[[6-(4-chlorophenoxy)pyridin-3-yl]…
TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics …
…, H Takano, H Koretsune, C Koizumi, E Kunioka… - European Journal of …, 2018 - Elsevier
Hypoxia-inducible factor prolyl hydroxylases (PHDs) inhibitor stabilizes hypoxia inducible
factor alpha, which increases erythropoietin (EPO) expression via the hypoxia response …
factor alpha, which increases erythropoietin (EPO) expression via the hypoxia response …
Cloning and expression of the secA gene of a marine bacterium, Vibrio alginolyticus, and analysis of its function in Escherichia coli
E Kunioka, S Matsuyama, H Tokuda - Gene, 1998 - Elsevier
We report the cloning, sequencing and functional characterization of the secA gene of a marine
bacterium, Vibrio alginolyticus, which has been suggested to utilize ATP and the sodium …
bacterium, Vibrio alginolyticus, which has been suggested to utilize ATP and the sodium …
[BOOK][B] Soviet science and engineering in the shadow of the Cold War
H Ichikawa - 2018 - taylorfrancis.com
… The author would also like to express his sincere thanks for the scientific support and
encouragement from the late professor Kunioki Katô, the late professor Toshio Yamazaki, Prof. …
encouragement from the late professor Kunioki Katô, the late professor Toshio Yamazaki, Prof. …
[BOOK][B] Introducing Japanese popular culture
A Freedman, T Slade - 2018 - api.taylorfrancis.com
… Laura Miller is the Ei’ichi Shibusawa-Seigo Arai Endowed Professor of Japanese Studies
at the University of Missouri–St. Louis, US. She has published more than seventy articles and …
at the University of Missouri–St. Louis, US. She has published more than seventy articles and …
Balancing innovation, access, and profits—market exclusivity for biologics
AB Engelberg, AS Kesselheim… - New England Journal of …, 2009 - Mass Medical Soc
Alfred Engelberg and Drs. Aaron Kesselheim and Jerry Avorn discuss proposed bills that
would guarantee manufacturers 12 years of market exclusivity for a new biologic agent before …
would guarantee manufacturers 12 years of market exclusivity for a new biologic agent before …
Albini, Angelo, 1426 Albrecht-Gary, Anne-Mane, Alcalde, Ermitas, 734 Alcock, Nathaniel W., 614, Aldebert, Pierre, 1636
VD Alexiev, HR Allcock, BL Allwood, H Alper, HG Alt… - pubs.rsc.org
… , 743 Nambu, Yoko, 574 Namiki, Takahisa, 1472 Narisano, Enrica, 136, 138 Naruta,
Yoshinori, 972 Naylor, Ste hen, 1619 Nazar, Linfa F., 570 Nazran, Avtar S., 435 Negishi, Ei-ichi, …
Yoshinori, 972 Naylor, Ste hen, 1619 Nazar, Linfa F., 570 Nazran, Avtar S., 435 Negishi, Ei-ichi, …
Aso, Mariko, 102 Aso, Yoshio, 1447, 1816 Astles, David P., 400 Astruc, Didier, 667 Atkinson, Robert S., 456, 458
JE Baxter, ALJ Beckwith - pubs.rsc.org
… , Nurani S., 191 Narayana, Chatla, 1857 Narula, Chaitanya K., 496 Nasielski, Jacques, 1821
Natsugari, Hideaki, 62 Naylor, Matthew, 1088 Naylor, Stephen, 1408 Negishi, Ei-ichi, 477 …
Natsugari, Hideaki, 62 Naylor, Matthew, 1088 Naylor, Stephen, 1408 Negishi, Ei-ichi, 477 …